View Previous Lab-to-Table Conversations here!
Sign up here to receive an invitation to our monthly conversations!
September 29, 2022, 11:00 a.m. – 12:00 p.m. CT, via Zoom
“Biomedical Research Ethics and the Scientific Method”
The COVID-19 pandemic has brought biomedical research to the forefront of conversation. From vaccine and drug development to “gain of function” research and more, questions about biomedical ethics have become dinner table conversations. But to adequately engage in a discussion on ethical best practices of biomedical research and therapeutic development, it’s important to understand exactly what the “scientific method” entails. What safeguards are in place to prevent unintentional errors or fraud? How does the scientific community think about these questions?
Join Hassane Mchaourab, Ph.D., as he explores these topics in the next Lab-to-Table Conversation from the Vanderbilt University School of Medicine Basic Sciences. Mchaourab, the Louise B. McGavock Chair of Molecular Physiology and Biophysics, is passionate about scientific integrity and regularly presents to trainees and peers about responsible conduct in research.
The event will take place on September 29 at 11:00 a.m.–12:00 p.m. CDT and will feature panelists:
- Ellen Wright Clayton, J.D., M.D. – Craig-Weaver Professor of Pediatrics, professor of law and health policy, co-founder of the Center for Biomedical Ethics and Society, and international expert in law and genomics.
- Mark Denison, M.D. – Edward Claiborne Stahlman Professor in Pediatrics, director of the Division of Pediatric Infectious Diseases, and expert in coronaviruses.
- Matthew Schrag, M.D., Ph.D. – Assistant professor of neurology and director of the Cerebral Amyloid Angiopathy Clinic; recently found signs of data fabrication in major Alzheimer’s scientific articles.
August 25, 2022, 2:00 – 3:00 p.m. CT, via Zoom
“Childhood Trauma, Brain Development, and the Justice System”
One of the largest studies ever on childhood abuse and neglect is the CDC-Kaiser Permanente adverse childhood experiences (ACE) study, which showed direct correlation of ACEs to health and well-being challenges in adolescence and adulthood including addiction and mental health. While 64% of the U.S. population has at least one ACE, 97% of the U.S. prison population has one or more according to the Compassion Prison Project. So how does childhood trauma impact brain development and behavior biologically? How does this lead to increased risk for incarceration? How can we integrate this understanding better into our justice system and diversion and prevention efforts? And how do we heal from ACEs individually and as a society?
Join Joey Barnett, Ph.D., professor of pharmacology, for the next Lab-to-Table Conversation from the Vanderbilt School of Medicine Basic Sciences in which we will explore these topics. Barnett has been volunteering with incarceration- and reentry-based programming since the 1980s.
This month, the event will take place on August 25 at 2:00 p.m.–3:00 p.m. CDT and will feature panelists:
- Pierre Cabell – musician, lead facilitator for Healing Broken Circles, and formerly incarcerated individual,
- Trina Frierson – president and CEO of Mending Hearts Inc., an organization working with women who are homeless due to addiction, most of which are in the reentry community,
- Richard Simerly, Ph.D. – Louise B. McGavock Professor of Molecular Physiology and Biophysics and expert in developmental neurobiology, and
- Mark Wallace, Ph.D. – Louise B. McGavock Chair of Neuroscience studying the neural bases of multisensory processing.
The panel will connect the neurobiology of how childhood trauma impacts brain development and behavior, its intersection with the justice system, and how we can integrate this understanding in our prevention, diversion, and restorative efforts.
July 27, 2022, 12:00 – 1:00 p.m. CT, via Zoom
“Scientist-Artists: Embracing Duality”
In ancient times and during the Renaissance, scientists and artists were often one and the same. Today, only “scientific geniuses” are considered to be polymaths—people with extensive knowledge on a variety of subjects.
Yet, arts and creative avocations in scientists are more common than typically portrayed. Now more than ever, people are recognizing and exploring how art and science interact and influence each other, both within research fields and scientist-artists themselves.
Join Kendra Oliver, Ph.D., assistant professor of pharmacology and director and founder of ArtLab, for our next Lab-to-Table Conversation in which we will explore how a group of self-identified scientist-artists are embracing this particular duality.
This month, the event will take place on July 27 at 12:00 p.m.–1:00 p.m. CDT and will feature panelists:
• Ian Macara, Ph.D. – chair of the department of cell and developmental biology,
• Navya Thakkar – Vanderbilt alumna who studied biology and studio art and winner of the Margaret Stonewall Wooldridge Hamblet Award,
• Kate Mittendorf, Ph.D. – senior staff scientist at Vanderbilt University Medical Center, illustrator, and Vanderbilt Ph.D. graduate, and
• Jacob Steenwyk, Ph.D. – scientific consultant at LatchBio, founder and chief officer of The SciArt Shop, and Vanderbilt Ph.D. graduate.
The panel will discuss their individual identities as both scientists and artists, showcase their art and research, and discuss the influence of art on science and science on art.
The event is free, virtual, and open to the public.
June 30, 2022, 12:00 – 1:00 p.m. CT, via Zoom
“Reconcilable differences: A conversation about religion and science”
Religion and science are often thought of as holding opposing worldviews, but what do religious leaders and scientists think about the dialogue between religion and science? Does it have to be a choice between religion or science, or is there common ground?
The panel will discuss Christian, Islamic, and Jewish perspectives about the dialogue between religion and science, how religion and science can impact each other positively, and how to stem implicit biases on both sides of the dialogue, among other topics. The panel will be moderated by:
• Alyssa Hasty, Ph.D, Cornelius Vanderbilt Professor of Molecular Physiology and Biophysics and associate dean for faculty in the School of Medicine Basic Sciences, and will feature panelists:
• Imam Ossama Bahloul, Ph.D. – resident scholar of the Islamic Center of Nashville,
• Maureen Gannon, Ph.D. – professor of medicine and associate dean for faculty development in the Vanderbilt School of Medicine,
• Paul Lim, Ph.D. – associate professor of the history of Christianity at the Vanderbilt Divinity School, and
• Rabbi Shana Goldstein Mackler – rabbi at The Temple–Congregation Ohabai Sholom in Nashville.
May 24, 2022, 12:00 – 1:00 p.m. CT, via Zoom
“AI and Machine Learning in Biomedical Research”
Access to big data and an increase in computation power through artificial intelligence and machine learning is changing the landscape of biomedical research. How are these new tools used and how are they leading to new discoveries? Are they able to make drug discovery cheaper, faster, and safer? What are the ethics of using these tools?
Join Ian Macara, Ph.D., chair and professor of the Department of Cell and Developmental Biology, for the next Lab-to-Table Conversation from the Vanderbilt University School of Medicine Basic Sciences. This month, the event will take place on May 24 at 12:00 p.m.–1:00 p.m. CDT and will feature panelists:
• André Bastos, Ph.D. – an assistant professor of psychology who uses computational modeling to unravel how the brain builds predictions,
• Shannon Smith – a Ph.D. student in the lab of Jens Meiler who uses machine learning for drug development, and
• Jesse Spencer-Smith, Ph.D. – Chief Data Scientist at the Vanderbilt Data Science Institute.
The panel will discuss the use and impact of artificial intelligence and machine learning on biomedical research, how it is being used for new and paradigm-shifting discoveries, and its ethics.
April 26, 2022, 7:00 – 8:30 p.m. CT, Blair School’s Ingram Hall
“Survivor: Intersections of Cancer and Mental Health with Ethan Zohn”
Ethan Zohn, winner of the CBS reality show Survivor, two-time cancer survivor, humanitarian and former professional soccer player, will discuss his journey with reality television, cancer, mental health and humanitarian work as part of the School of Medicine Basic Sciences’ monthly Lab-to-Table Conversations on Tuesday, April 26. The event is free and open to the public, and no registration is required. The discussion will be moderated by Larry Marnett, dean of the Vanderbilt University School of Medicine Basic Sciences and include Brian Engelhardt, associate professor of medicine of hematology and oncology at the Vanderbilt University Medical Center, and William Tansey, Ingram Professor of Cancer Research at the School of Medicine Basic Sciences.
The event will include an audience Q&A. If you would like to submit a question in advance, please fill out this form. At the end of the event, there will be a meet and greet with Zohn.
March 10, 2022, 12:00 p.m. CT
“The COVID Conundrum: What’s Next”
Panelists will talk about the trajectory of variants, global travel, and the accessibility and equity of vaccines and boosters, among other timely topics.
Chancellor Daniel Diermeier will host the event with opening remarks. The virtual panel is hosted by the Vanderbilt Chancellor’s Lecture Series in partnership with the Vanderbilt School of Medicine Basic Sciences.
The event is open to all.
The panel discussion will be moderated by Melinda J.B. Buntin, Mike Curb Professor and chair of the Department of Health Policy.
- Dr. Consuelo Wilkins, senior vice president and senior associate dean for health equity and inclusive excellence, and associate director of the Vanderbilt Institute for Clinical and Translational Science
- Dr. William Schaffner, professor of preventive medicine and health policy in the Division of Infectious Diseases
- Dr. C. Buddy Creech, Edie Carell Johnson Professor of Pediatrics in the Division of Pediatric Infectious Diseases and director of the Vanderbilt Vaccine Research Program
February 22, 2022, 12:00 p.m. CT
“Black Excellence in Research and the Future of Diversity in Academia”
In recognition of Black History Month, please join the monthly, virtual Vanderbilt School of Medicine Basic Sciences Lab-to-Table Conversations to celebrate Black excellence in research and to discuss the future of diversity in academia.
The webinar will be moderated by Antentor Hinton Jr., assistant professor of molecular physiology and biophysics, with the following panelists:
- Calvin Carter, Ph.D. – assistant professor of neuroscience and pharmacology at the University of Iowa and co-founder and president of Geminii Health,
- Jamaine Davis, Ph.D. – assistant professor of biochemistry and cancer biology at Meharry Medical College,
- Elsie Spencer, Ed.D. – administrative director of the National Center for Children and Families, and center administrator for the Consortium for Policy Research in Education at the Teachers College at Columbia University, and
- Brittany Taylor, Ph.D. – assistant professor of biomedical engineering at the University of Florida.
The panel will discuss the impacts of Black scientists on their fields of study, the current faculty climate and how inclusion and equity can continue their upward trajectory, STEM pipeline development and access, and hopes for the future of diversity in academia.
January 31, 2022, 12:00 p.m. CT
“The Science of Flavor”
Flavor combinations in food bring enjoyment, nostalgia, nutrition and conversation. But where do flavors come from? What is their chemistry? How is the scientific understanding of flavor changing? And how is this science impacting industry and restaurants?
On Monday, Jan. 31, from noon to 1 p.m. CT, the School of Medicine Basic Sciences’ monthly virtual Lab-to-Table Conversation will discuss the history of flavor science, how it has changed, and how it is being applied in the restaurant space and in industry.
The panel will be moderated by Larry Marnett, dean of the Vanderbilt University School of Medicine Basic Sciences, with panelists:
• John York, chief science officer at Impossible Foods and former chair of Vanderbilt’s Department of Biochemistry;
• Vivek Surti, Vanderbilt alumnus and founder of Tailor Nashville, named one of the best new restaurants nationally by Bon Appétit magazine in 2019; and
• Xiaodong “Sheldon” Li, founder and CEO of Ixora Taste Sciences Inc., a startup dedicated to the discovery of natural taste modulators, and an expert in taste modulation, taste receptors, and related chemistry.
December 16, 2021, 11:00 a.m. CT
“The Science of Beer”
Beer dates to the 5th millennium BC and is one of the oldest drinks humans have produced. The process of refining the fermentation and production of beer has been part of human history. But what is the science of beer and how does it connect to biomedical research?
For the Vanderbilt School of Medicine Basic Sciences’ monthly virtual Lab-to-Table Conversation on December 16 at 11:00am – 12:00pm, join Bruce Carter, professor of biochemistry, associate director of the Vanderbilt Brain Institute, and beer science expert with panelists:
• Bailey Spaulding, JD – CEO and founder of Jackalope Brewing Company and Vanderbilt University Law School alum,
• Linus Hall, MBA – President and co-founder of Yazoo Brewing Company and Vanderbilt University Owen Graduate School of Management alum, and
• Andrzej Balinski, MS – Research core facility manager in the Vanderbilt University Department of Chemistry and beer science expert.
The panel will discuss the history of beer both globally and in Nashville, the science of beer and fermentation, how this science has changed in modern times, and how beer and fermentation science connect to biomedical processes in the body.
November 30, 2021, 11:00 a.m. CT
“The Science of Longevity” Biomedical science has made huge strides in understanding the mechanics of human aging, and these discoveries have drastically affected how we work to prevent disease and increase longevity.
On Tuesday, Nov. 30, 11 a.m.–noon CT, the School of Medicine Basic Sciences’ monthly virtual Lab-to-Table Conversation will bring aging research experts together and outline our current understanding of the biology of longevity, where longevity research is heading and how people can incorporate our current understanding into their day-to-day lives.
The panel will be moderated by Vanderbilt alumna Dr. Laura Niedernhofer, director of the Institute on the Biology of Aging and Metabolism at University of Minnesota, and include current Vanderbilt faculty:
Rafael Arrojo e Drigo, assistant professor of molecular physiology and biophysics
Kris Burkewitz, assistant professor of cell and developmental biology
Laura Dugan, Abram C. Shmerling, MD Chair in Alzheimer’s and Geriatric Medicine and professor of medicine at the Vanderbilt University Medical Center
October 12, 2021, 12:00 p.m. CT
“Jason Isbell: Songs and Sobriety” Four-time Grammy award-winning musician Jason Isbell joins a panel moderated by Danny Winder, director of the Vanderbilt Center for Addiction Research, and Erin Calipari, assistant professor of pharmacology. The discussion will cover the impacts of COVID-19 on addiction and sobriety, the stigma of addiction, and the intersections of sobriety, addiction, and music. Featured guest Jason Isbell has had personal experience with addiction and sobriety, which has influenced his music and work over the last decade. This has included his 2013 album Southeastern, his first after getting sober, as well as more recent songs like “It Gets Easier” and work with Bradley Cooper on the movie “A Star Is Born.”
September 23, 2021, 12:00 p.m. CT
“In the Weed(s): A Panel on Medical Marijuana, CBD, and Delta 8” With the growing legalization of medical and recreational marijuana in states across the country, as well as growth in use of CBD and Delta 8, what does current science say about the efficacy of its use and its short and long-term impacts on your body? What are the current legal trends for these substances in the United States?
To delve into these questions, please join Larry Marnett, Ph.D., dean of the Vanderbilt University School of Medicine Basic Sciences, for the school’s monthly Lab-to-Table Conversation, where he will be moderating a conversation about the science of marijuana and the current legal context for its use with the following panelists:
• Ziva Cooper, Ph.D. – director of the UCLA Cannabis Research Initiative and associate professor in psychiatry and anesthesiology at UCLA,
• Robert Mikos, J.D. – LaRoche Family Chair in Law at the Vanderbilt Law School, expert on marijuana law and author of the book Marijuana Law, Policy, and Authority, and
• Dr. Sachin Patel, M.D., Ph.D., James G. Blakemore Professor of Psychiatry and Behavioral Sciences, Molecular Physiology and Biophysics, and director of the division of general psychiatry at Vanderbilt University Medical Center.
August 17, 2021, 11:00 A.M. CT
“Watts, Metabolism, Data Analytics: Science’s Impact on Cycling Over 25 Years” Over the past few decades, biomedical science has made huge strides in understanding how the human body works. New scientific insights have drastically impacted how endurance sports athletes train and eat. For the monthly Vanderbilt University School of Medicine Basic Sciences Lab-to-Table Conversation, join Matt Tyska, Cornelius Vanderbilt Chair and professor of cell and developmental biology, as he moderates a conversation about science and cycling with the following panelists:
• George Hincapie, former professional cyclist, 17-time Tour de France rider, owner of Hincapie Sportswear, and a co-host of the THEMOVE podcast,
• Bobby Julich, former professional cyclist, Tour de France veteran, Olympic medalist, cycling coach, and host of the Bobby & Jens podcast, and
• Dr. Kevin Sprouse, head of medicine for EF Education-NIPPO Pro Cycling, and sports medicine provider for PGA golfers, NFL and MLB players, Olympic track and field athletes, and more.
The panel will discuss their personal experiences with training, coaching, and medicine in cycling and how science has impacted their efforts through the years.
July 27, 2021
“Toward a Cure for Melanoma” With the peak of summer approaching, this panel will discuss innovative research in melanoma and how it could move the needle towards less toxic treatments and better outcomes for patients. Moderated by Ann Richmond, Ph.D., Ingram Professor of Cancer Research and professor of pharmacology, the panel will feature: Justin Balko, Pharm.D., Ph.D., associate professor of medicine and pathology, microbiology and immunology, and Leader of Molecular Oncology, Center for Cancer Targeted Therapies Researcher; Dr. Anthony Daniels, M.Sc., M.D., assistant professor of ophthalmology and visual sciences, cancer biology, and radiation oncology; Dr. Doug Johnson, M.D., M.S.C.I., assistant professor of medicine of hematology/oncology; Dr. Caroline Nebhan, M.D., Ph.D., clinical fellow in hematology/oncology.
June 17, 2021
“Origins of Life: A conversation between a cell biologist, theologian, astronomer, and philosopher” How do academics with diverse areas of expertise view the origins of life? What kind of conversation would take place among a cell biologist, a theologian, an astronomer/physicist and a philosopher if they all sat around the same table? Witness this virtual discussion hosted by the School of Medicine Basic Sciences that will bring together perspectives from single-cell biology, theology, space and time and metaphysical philosophy to explore the unique and common understandings among the fields. The discussion will be moderated by Ian Marcara, Louise B. McGavock Chair and chair of the department of cell and developmental biology. The panelists are: Ellen Armour, PhD, E. Rhodes and Leona B. Carpenter Chair in religion, gender and sexuality Lenn Goodman, Andrew W. Mellon Professor in the Humanities, and professor of philosophy Stephen Taylor, assistant professor of physics and astronomy
May 26, 2021
“How the Brain Remembers” — a Conversation with New York Times bestselling author and neuroscientist Lisa Genova and Vanderbilt Brain Institute Barlow Family Director Lisa Monteggia. This event was presented in partnership with Nashville-based Parnassus Books.
April 21, 2021
“Addiction, Sobriety and Art in the Time of COVID-19”
Featured guest, Will Welch, global editorial director of GQ magazine will join Winder and Calipari for the discussion. Welch has had personal experience with addiction and sobriety and has made discussing these issues through articles like “Creating While Clean” a focus of GQ in recent years.
March 30, 2021
“On the Cutting-Edge: Research Toward a Cure for Colorectal Cancer”
Featuring David Cortez (moderator) and panelists Jordan Berlin, Robert Coffey, Ethan Lee, and Alissa Weaver.
October 6, 2020
“Depression and the Brain: A Paradigm Shift in Psychiatry and Neuroscience”
October is depression awareness month. An estimated 17.3 million adults in the United States had at least one major depressive episode in 2017. This number represented 7.1% of all U.S. adults. To align with awareness on this illness, Dr. Lisa Monteggia covers the ground-breaking research occurring in basic science focused on depression, which she counts as one of our strongest research areas. Dr. Monteggia discussed the recent breakthroughs and future directions our research will take.
July 3, 2020
“A Promising Start to Ending Coronaviruses”
Featuring Stephen W. Fesik, Orrin H. Ingram II Chair in Cancer Research. Steve Fesik, PhD, discusses his research on protease inhibitors for coronaviruses.
August 4, 2020
“Meeting the Challenge: Neuroscience Drug Discovery with the Warren Center”
The Warren Center for Neuroscience Drug Discovery (WCNDD) extends traditional academic pursuits in basic science to take the most exciting advances in our understanding of human disease and drug targets to a point where these breakthroughs can directly impact patient care. This is especially true in discovery of new treatment strategies for the most serious of brain disorders, such as Alzheimer’s disease, Parkinson’s disease, schizophrenia, autism, and others. By incorporating the highest level of drug discovery into academic research, the WCNDD takes scientific breakthroughs beyond the lab and toward the development of patentable and marketable drugs suited for clinical studies. Jeff Conn and Craig Lindsley give an overview of WCNDD, their neuroscience research and describe the impact of the transformative gift from The William K. Warren Foundation.